Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™
ABIM Diplomates - maximum of 0.25 ABIM MOC points
Nurses - 0.25 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)
Pharmacists - 0.25 Knowledge-based ACPE (0.025 CEUs)
Physician Assistant - 0.25 AAPA hour(s) of Category I credit
IPCE - 0.25 Interprofessional Continuing Education (IPCE) credit
This activity is intended for primary care physicians, cardiologists, sleep medicine specialists, nurses, pharmacists, physician assistants, and other members of the healthcare team who care for patients at risk for atherosclerosis.
The goal of this activity is for learners to be better able to analyze the associations between variations in sleep duration and sleep timing and measures of atherosclerosis.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.00 contact hours are in the area of pharmacology.
Medscape designates this continuing education activity for 0.25 contact hour(s) (0.025 CEUs) (Universal Activity Number: JA0007105-0000-23-110-H01-P).
Medscape, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until 03/24/2024. PAs should only claim credit commensurate with the extent of their participation.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive
AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC / CE Released: 3/24/2023
Valid for credit through: 3/24/2024
processing....
Sleep has been increasingly recognized as an important element of overall wellness, and a systematic review by Laksono and colleagues described the relationship between abnormal sleep duration and the risk for cardiovascular disease (CVD). The authors of this study combined evidence from 10 trials with a total of more than 360,000 adults, and their results were published in the February 7, 2022 issue of Sleep Disorders.[1]
In 9 of the 10 included studies, sleep duration had a significant effect on cardiovascular (CV) outcomes. Short sleep duration was significantly associated with higher risks for hypertension, coronary heart disease, and a combined outcome of atrial fibrillation, myocardial infarction, and stroke. Long sleep duration was associated with higher risks for atrial fibrillation and coronary heart disease.
Although this research corroborates other studies linking abnormal sleep to worse CV outcomes, there has been little research focused on the relationship between sleep and atherosclerotic disease itself. The current study by Full and colleagues addresses this issue.
Irregular sleep -- such as inconsistent sleep duration or sleep timing -- may increase the risk of developing atherosclerosis among adults older than age 45 years, a new report suggests.
In particular, variation in sleep duration of more than 2 hours per night in the same week was tied to higher rates of atherosclerosis.
"Poor sleep is linked with several [CV] conditions, including heart disease, hypertension, and type 2 diabetes," lead author Kelsie M. Full, PhD, MPH, assistant professor of medicine at Vanderbilt University Medical Center, Nashville, Tennessee, told theheart.org | Medscape Cardiology.
"Overall, we found that participants who slept varying amounts of hours throughout the week (meaning that one night they slept less, one night they slept more) were more likely to have atherosclerosis than participants who slept about the same amount of time each night," she said.
The study was published February 21 in the Journal of the American Heart Association.[2]
Analyzing AssociationsFull and colleagues examined data from 2032 participants in the Multi-Ethnic Study of Atherosclerosis (MESA) Sleep Ancillary Study, which included adults between the ages of 45 and 84 years in 6 US communities who completed 7-day wrist actigraphy assessment and kept a sleep diary between 2010 and 2013.
For subclinical markers of CVD, participants underwent assessments of coronary artery calcium (CAC), carotid plaque presence, carotid intima-media thickness, and ankle-brachial index (ABI).
The research team assessed sleep duration, or the total number of minutes of sleep in a night, and sleep timing regularity, which was determined on the basis of the time someone initially fell asleep each night. They adjusted for CVD risk factors and sleep characteristics, such as obstructive sleep apnea (OSA), sleep duration, and sleep fragmentation.
The mean age of the participants was 68.6 ± 9.2 years, and 53.6% were women. About 37.9% identified as White, 27.6% as Black, 23.4% as Hispanic American, and 11.1% as Chinese American.
During the 7-day period, about 38% of participants experienced a change in sleep duration of more than 90 minutes, and 18% experienced a sleep duration change of more than 120 minutes. Participants who had irregular sleep were more likely to be non-White, current smokers, have lower average annual incomes, have work shift schedules or did not work, and have a higher average body mass index (BMI).
For the study, sleep duration irregularity was defined as a sleep deviation [SD] of more than 120 minutes. Those participants who had a greater degree of sleep irregularity were more likely to have high CAC burden than participants whose sleep duration was more regular, defined as an SD of 60 minutes or less (> 300; prevalence ratio [PR] 1.33 [95% CI: 1.03, 1.71]), as well as abnormal ABI (< 0.9; PR 1.75 [95% CI: 1.03, 2.95]).
Further, participants with irregular sleep timing (SD > 90 minutes) were more likely to have a high CAC burden (PR 1.39 [95% CI: 1.07, 1.82]) in comparison with participants with more regular sleep timing (SD ≤ 30 minutes).
"The biggest surprise to me was that 30% of the participants in the study had total sleep times that varied by more than 90 minutes over the course of the week," Full said. "This is consistent with prior studies that suggest that a large proportion of the general public have irregular sleep patterns, not just shift workers."
Investigating Next StepsIn additional analyses, Full and colleagues found that sleep duration regularity continued to be associated with high CAC burden and abnormal ABI when accounting for severe OSA, average nightly sleep duration, and average sleep fragmentation.
Notably, when sleep duration was added, all participants with more irregular sleep durations (SD > 60 minutes) were more likely to have a high CAC burden as compared with participants with regular sleep durations (SD ≤ 60 minutes). The results remained when participants who reported shift work, including night shift work, were excluded.
Additional studies are needed to understand the mechanisms, the study authors wrote. Night-to-night variability in sleep duration and sleep timing can cause desynchronization in the sleep-wake timing and circadian disruption.
"A key issue highlighted in this study is that sleep irregularity itself, independent of how much sleep people were getting, was related to heart health. Sleep is a naturally recurring phenomenon, and maintaining regularity helps provide stability and predictability to the body," Michael Grandner, PhD, associate professor of psychiatry and director of the Sleep and Health Research Program at the University of Arizona College of Medicine, Tucson, Arizona, told Medscape Medical News.
Grandner, who was not involved with this study, has researched sleep irregularity and associations with CVD, diabetes, obesity, and many other adverse outcomes.
"When people have very irregular sleep schedules, it may make it harder for the body to optimally make good use of the sleep it is getting, since it such a moving target," he said. "The unique angle here is the ability to focus on regularity of sleep."
The study was supported by the National Heart, Lung, and Blood Institute and the National Center for Advancing Translational Sciences of the National Institutes of Health. One author received grants and consulting fees from pharmaceutical companies unrelated to the research. The other authors and Grandner have disclosed no relevant financial relationships.